Showing results (271-280 of 399) with videos related to

Sort By:
Pageof 40
Nature Communications|August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Cancer Discovery|June 15, 2013
Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer driversDaniel Hagerstrand, Alexander Tong, Steven E Schumacher, et al.
Open Forum Infectious Diseases|August 14, 2015
Epidemiologic Investigation of a Cluster of Neuroinvasive Bacillus cereus Infections in 5 Patients With Acute Myelogenous LeukemiaChanu Rhee, Michael Klompas, Fiona B Tamburini, et al.
Leukemia|April 9, 2025
Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final resultsAndreas Hochhaus, Dong-Wook Kim, Jorge E Cortes, et al.
Leukemia|May 16, 2024
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up resultsJorge E Cortes, Koji Sasaki, Dong-Wook Kim, et al.
Cancer Research Communications|June 4, 2026
CAR T-Cell Kinetics, Persistence and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-Cell ALL Treated with Obecabtagene Autoleucel in the FELIX StudyClaire Roddie, William Day, Meera Raymond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell NeoplasmNaveen Pemmaraju, Giovanni Marconi, Pau Montesinos, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemiaEmma-Jayne Minihane, Leah Krotee, Jason Wu, et al.
Cell Reports. Medicine|June 21, 2025
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platformYuqing Zhang, Zehua Li, Jessica Ritter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute LeukemiaEytan M Stein, Daniel J DeAngelo, Jörg Chromik, et al.
Pageof 40